Trial Profile
Pharmacodynamics of teriparatide versus isedronic acid in women with postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary) ; Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Pharmacodynamics
- 05 Nov 2010 New trial record.